See Every Facet of the Story.
Published loading...Updated

Research shows minimally invasive procedure saves most patients with severe vascular disease from amputation

Summary by Ground News
LimFlow therapy could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to limb loss. LimFlow bypasses blocked arteries in the leg and rush blood back into the foot through the veins. At six months post-procedure, 76 percent of patients were able to keep their leg (also called limb salvage)

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Business Wire broke the news in Crystal River, United States on Thursday, March 30, 2023.
Sources are mostly out of (0)

Similar News Topics